NEW YORK, Feb. 17, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
Protective Insurance Corporation (NASDAQ: PTVCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to The Progressive Corporation for $23.30 in cash for each share of Protective Class A and Class B common stock. If you are a Protective shareholder, click here to learn more about your rights and options.
Aegion Corporation (NASDAQ: AEGN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to affiliates of New Mountain Capital, L.L.C for $26.00 per share in cash. If you are an Aegion shareholder, click here to learn more about your rights and options.
Cardtronics plc (NASDAQ: CATM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to NCR Corporation for $39.00 per share in cash. If you are a Cardtronics shareholder, click here to learn more about your rights and options.
Change Healthcare Inc. (NASDAQ: CHNG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Optum, a company that is part of UnitedHealth Group. Under the merger agreement, Change Healthcare shareholders will receive $25.75 per share in cash. If you are a Change Healthcare shareholder, click here to learn more about your rights and options.
GW Pharmaceuticals plc (NASDAQ: GWPH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Jazz Pharmaceuticals plc for $200.00 in cash and $20.00 in Jazz ordinary shares for each GW American Depositary Share (ADS). If you are a GW Pharmaceuticals shareholder, click here to learn more about your rights and options.
Pluralsight, Inc. (NASDAQ: PS) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Vista Equity Partners for $20.26 per share. If you are a Pluralsight shareholder, click here to learn more about your rights and options.
Seneca Biopharma, Inc. (NASDAQ: SNCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Leading BioSciences, Inc. If you are a Seneca shareholder, click here to learn more about your rights and options.
Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
SOURCE Halper Sadeh LLP
![](https://rt.prnewswire.com/rt.gif?NewsItemId=NY82625&Transmission_Id=202102171321PR_NEWS_USPR_____NY82625&DateId=20210217)
Share this article